Cellid셀리드
299660 · KOSDAQ · ₩299660 · 셀리드
₩2,125▲ ₩40 (1.92%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 18.5% | 17.8% | 16.9% | — | 32.4% | 100.0% |
| Operating margin | −99.3% | −128.3% | −287.6% | — | −3,106.5% | −1,431.2% |
| Net margin | −262.8% | −136.5% | −294.3% | — | −4,763.5% | −1,437.8% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +17.9% | +112.3% | — | — | −47.2% | — |
| Operating income growth | +8.8% | +5.3% | +1.8% | +18.2% | −14.6% | — |
| Net income growth | −126.9% | +1.5% | −5.6% | +49.2% | −74.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −42.8% | −19.2% | −26.7% | −36.9% | −74.7% | −33.7% |
| Return on assets | −26.4% | −12.9% | −17.5% | −21.2% | −43.9% | −22.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 80.4% | 49.4% | 48.6% | 57.9% | 104.4% | 50.3% |
| Net debt to equity | 31.2% | 7.1% | 7.9% | −8.4% | −19.5% | 6.7% |
| Current ratio | 57.5% | 83.0% | 231.6% | 163.4% | 102.1% | 1,127.1% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Cellid / 셀리드 / 299660 / KRX:299660
Source: KRX statistical information